Fulgent Genetics, Inc.
FLGTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Fulgent Genetics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 3, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| CWM, LLC | 2026-03-31 | 4,310 | $68.5K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 584,207 | $9.29M | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 296 | $4.71K | SEC filing |
| Leonteq Securities AG | 2026-03-31 | 43 | $684 | SEC filing |
| Invenomic Capital Management LP | 2026-03-31 | 610,318 | $9.7M | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 12,579 | $200K | SEC filing |
| VISION FINANCIAL MARKETS LLC | 2026-03-31 | 100 | $1.59K | SEC filing |
| Diametric Capital, LP | 2026-03-31 | 361,046 | $5.74M | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 29,424 | $468K | SEC filing |
| Peapod Lane Capital LLC | 2026-03-31 | 220,627 | $3.49M | SEC filing |
| Hennion & Walsh Asset Management, Inc. | 2026-03-31 | 84,010 | $1.34M | SEC filing |
| Abound Wealth Management | 2026-03-31 | 56 | $891 | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 2,691 | $42.8K | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 401,819 | $6.39M | SEC filing |
| Main Street Group, LTD | 2026-03-31 | 100 | $1.59K | SEC filing |
| LEVIN CAPITAL STRATEGIES, L.P. | 2026-03-31 | 43,234 | $687K | SEC filing |
| FEDERATED HERMES, INC. | 2026-03-31 | 49,207 | $782K | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 24,640 | $392K | SEC filing |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 56,309 | $895K | SEC filing |
| Allworth Financial LP | 2026-03-31 | 182 | $2.89K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Fulgent Genetics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-19 · Xie Jian: Larger than all 36 other insider sales of Common Stock on file. SEC filing
- 2024-08-27 · Hsieh Ming: Larger than 33 of the 36 other insider sales of Common Stock on file. SEC filing
- 2021-03-11 · Xie Jian: Larger than 35 of the 36 other insider sales of Common Stock on file. SEC filing
- 2021-03-10 · Xie Jian: Larger than 34 of the 36 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-02 | Xie Jian · President and COO | Common Stock | S — Open market or private sale | −2,146 | 17.89 | SEC filing |
| 2026-06-02 | Gao Hanlin · Chief Scientific Officer | Common Stock | S — Open market or private sale | −1,688 | 17.89 | SEC filing |
| 2026-05-27 | Xie Jian · President and COO | Common Stock | S — Open market or private sale | −1,201 | 17.60 | SEC filing |
| 2026-05-27 | Gao Hanlin · Chief Scientific Officer | Common Stock | S — Open market or private sale | −945 | 17.60 | SEC filing |
| 2025-12-02 | Gao Hanlin · Chief Scientific Officer | Common Stock | S — Open market or private sale | −1,075 | 28.33 | SEC filing |
| 2025-12-02 | Xie Jian · President and COO | Common Stock | S — Open market or private sale | −1,140 | 28.33 | SEC filing |
| 2025-11-28 | Gao Hanlin · Chief Scientific Officer | Common Stock | S — Open market or private sale | −943 | 29.57 | SEC filing |
| 2025-11-28 | Xie Jian · President and COO | Common Stock | S — Open market or private sale | −1,198 | 29.57 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-01 | Kim Paul · CFO and Treasurer | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,087 | SEC filing |
| 2026-06-01 | Hsieh Ming · Chief Executive Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −4,392 | SEC filing |
| 2026-05-26 | Kim Paul · CFO and Treasurer | Common Stock | F — Payment of exercise price or tax by delivering securities | −1,168 | SEC filing |
| 2026-05-26 | Hsieh Ming · Chief Executive Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,949 | SEC filing |
| 2026-05-14 | Dong Linda · Director | Common Stock | A — Grant, award, or other acquisition | +11,117 | SEC filing |
| 2026-05-14 | Nohaile Michael · Director | Common Stock | A — Grant, award, or other acquisition | +5,558 | SEC filing |
| 2026-05-14 | Nohaile Michael · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +8,426 | SEC filing |
| 2026-05-14 | GROVES REGINA E · Director | Common Stock | A — Grant, award, or other acquisition | +11,117 | SEC filing |
Showing 8 of 21 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-09 (amended) | Hsieh Ming · Chief Executive Officer | Forward sale contract (obligation to sell) | J — Other acquisition or disposition | −750,000 | SEC filing |
| 2025-06-09 | Hsieh Ming · Chief Executive Officer | Forward sale contract (obligation to sell) | J — Other acquisition or disposition | −800,000 | SEC filing |
| 2024-03-08 | Hsieh Ming · Chief Executive Officer | Forward sale contract (obligation to sell) | J — Other acquisition or disposition | +1,000,000 | SEC filing |
| 2024-03-08 | Hsieh Ming · Chief Executive Officer | Forward sale contract (obligation to sell) | J — Other acquisition or disposition | −1,000,000 | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.